Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06107504Recruiting
Randomised, open-label trial of sucralfate and tranexamic acid (2 arms), sponsored by National Cheng Kung University Hospital. Primary endpoint: The incident rate of delayed post-ERCP bleeding during the study period at 14 days. Started Jan 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06107504.